In adults with acute HF, high-intensity care vs. usual care reduced a composite of death or HF readmission at 180 d

Ann Intern Med. 2023 Mar;176(3):JC31. doi: 10.7326/J23-0005. Epub 2023 Mar 7.

Abstract

Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938-52. 36356631.

Publication types

  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Adult
  • Heart Failure* / therapy
  • Humans
  • Patient Readmission*
  • Stroke Volume